Grafa News and Videos — Page 475

NVIDIA (NASDAQ:NVDA) placed its Groq 3 LPX AI inference accelerator into full production to process agentic workloads at 3,400 tokens per second.

The United States is preparing to expand its economic sanctions against Iran, with the measures expected to target Iran's revenue streams and trade networks in an effort to intensify economic pressure on Tehran, according to a report by the New York Times.

Boeing (NYSE:BA) engineers and technical workers rejected a four-year contract offer from the company, with members of the Society of Professional Engineering Employees in Aerospace authorizing a potential strike after the contract expires in October.

Tesla (NASDAQ:TSLA) announced plans to unveil the production version of its Cybercab robotaxi at a launch event in Austin, Texas, on September 3.

REGENXBIO (NASDAQ:RGNX) reported that the U.S. Food and Drug Administration placed a clinical hold on its investigational MPS II gene therapy RGX-121 following spine MRI findings in five participants in the CAMPSIITE study.

Monte Rosa Therapeutics (NASDAQ:GLUE) announced that the first patient has been dosed in MODeFIRe-1, a Phase 2 trial evaluating investigational molecular glue degrader MRT-2359 with apalutamide in patients with AR mutation-positive metastatic castration-resistant prostate cancer.

VERAXA Biotech (NASDAQ:VRXA) and Secarna Pharmaceuticals announced a research milestone in their collaboration to develop antibody-oligonucleotide conjugates for autoimmune and chronic immune diseases.

Philip Morris International (NYSE:PM) announced that its non-U.S. affiliates entered a contract manufacturing arrangement with Philip Morris USA, an operating company of Altria (NYSE:MO), for combustible cigarettes.

TwinStrand Biosciences announced that the U.S. District Court for the District of Delaware entered final judgment in favor of TwinStrand and the University of Washington in their patent infringement case against Guardant Health (NASDAQ:GH), awarding more than $245.2 million in damages, royalties, and interest.

Booz Allen Hamilton (NYSE:BAH) completed its previously announced $720 million acquisition of Ultra I&C Mission Solutions, expanding its defense technology capabilities for national security customers.